ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 254665 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 254665; 2) Community: the network communities that were significantly associated with the response to NSC 254665; 3) Molecule: the relationships between components within communities and NSC 254665; 4) MDR: the compounds that were significantly associated with the NSC 254665.

NSC Compound Enrichment Correlation
NSC 117274 Null 0.0385613993886001 0.39807668
NSC 13318 Null 0.0385613993886001 0.31519911
NSC 179187 Salasdine 0.0385613993886001 -0.071449497
NSC 24189 Null 0.0385613993886001 0.1863724
NSC 268242 N,N-Dibenzyldaunorubicin 0.0385613993886001 0.40989834
NSC 299117 24-Norchola-20,22-diene-4-carboxaldehyde, 3,12-bis(acetyloxy)-14,15:21,23-diepoxy-1,7,19-trihydroxy-4,8-dimethyl-11-oxo-, cyclic 4,19-(acetyl acetal), [1.alpha.,3.alpha.,4.beta.(S),5.alpha.,7.alpha., 0.0385613993886001 0.47508287
NSC 382034 2,4-Pyrimidinediamine, 6-ethyl-5-[4-(methylamino)- 3-nitrophenyl]- 0.0385613993886001 0.35588234
NSC 639518 Cyclopentanone, 2-[[4-(benzoyloxy)-3-methoxyphenyl] methylene]-5-[(dimethylamino)methyl]-, hydrochloride 0.0385613993886001 0.28713206
NSC 651850 Null 0.0385613993886001 0.060406381
NSC 654509 Pirarubicin HCl 0.0385613993886001 0.16602931
Total:43  Current:31    [First] [Prev] [Next] [Last]